← Evidence map

ReviewExpert opinion on pharmacotherapy2017

Latanoprostene bunod ophthalmic solution 0.024% for IOP lowering in glaucoma and ocular hypertension.

Paul L KaufmanPubMed ↗Publisher ↗

No numbers read from the abstract.

35 papers cite it

2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
this papertrialcites it
Full record →Abstract, authors, funding and every citing paper · PMID 28234563